Trial intelligence / Profile preview

Effect of propolis, clove, and chlorhexidine mouthwashes on oral hygiene and prevention of ventilator-associated pneumonia in the intensive care unit

IRCT20120215009014N597Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Mar 2026
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of propolis and chlorhexidine in ventilator-associated pneumonia (VAP) (3 arms), sponsored by Hamadan University of Medical Sciences. Started Mar 2026; status: completed.

02

Drugs

propolischlorhexidine
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on IRCT20120215009014N597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call